Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Cited by (1,128)

Items 501–600 of 1,128

1. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis
   Maja Eriksson, Oluf Andersen, Björn Runmarker · 2003 · Multiple Sclerosis Journal
2. Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage
   Maria Assunta Rocca, Andrea Falini, Bruno Colombo, Giuseppe Scotti, Giancarlo Comi, Massimo Filippi · 2002 · Annals of Neurology
3. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids
   Virgilio Gallai, Paola Sarchielli, Alberto Trequattrini, Maristella Franceschini, Ardesio Floridi, Caterina Firenze, Andrea Alberti, Daniela Di Benedetto, Eduardo Stragliotto · 1995 · Journal of Neuroimmunology
4. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
   Richard A. Nash, James D. Bowen, Peter A. McSweeney, Steven Zivko Pavletic, Kenneth R. Maravilla, Man-soo Park, Jan Storek, Keith M. Sullivan, Jinan Al-Omaishi, John R. Corboy et al. · 2003 · Blood
5. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
   D. Ontaneda, R. Fox, J. Chataway · 2015 · Lancet Neurology
6. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis
   Massimiliano Calabrese, Francesca Rinaldi, Paola Grossi, Irene Mattisi, Valentina Bernardi, Alice Favaretto, Paola Perini, Paolo Gallo · 2010 · Multiple Sclerosis Journal
7. Multiple Sclerosis: Effects of Cognitive Rehabilitation on Structural and Functional MR Imaging Measures—An Explorative Study
   Massimo Filippi, Gianna Carla Riccitelli, Flavia Mattioli, Ruggero Capra, Chiara Stampatori, Elisabetta Pagani, Paola Valsasina, Massimiliano Copetti, Andrea Falini, Gıancarlo Comı et al. · 2012 · Radiology
8. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis
   Howard Zwibel · 2009 · Advances in Therapy
9. Regional Magnetic Resonance Imaging Lesion Burden and Cognitive Function in Multiple Sclerosis
   Reisa Anne Sperling, Charles R.G. Guttmann, Marika J. Hohol, Simon Keith Warfield, Marianna Jakab, Marco Parente, Eli L. Diamond, Kirk R. Daffner, Michael J. Olek, Endel John Orav et al. · 2001 · Archives of Neurology
10. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging
    Cynthia A. Husted, Douglas S. Goodin, James W. Hugg, Andrew A. Maudsley, Jay S. Tsuruda, S. H. de Bie, George Fein, Gerald B. Matson, Michael Walter Weiner · 1994 · Annals of Neurology
11. Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H
    Andrea Paolillo, Alasdair J. Coles, P. D. Molyneux, Mary L Gawne-Cain, David G. MacManus, Gareth J. Barker, D. A. S. Compston, DH Miller · 1999 · Neurology
12. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
    Gıancarlo Comı, Nicola De Stefano, Mark S. Freedman, Frederik Barkhof, Chris H. Polman, Bernard M.J. Uitdehaag, Florence Casset‐Semanaz, Bryan T. Hennessy, Margaretha Stam Moraga, Sanda Rocak et al. · 2011 · The Lancet Neurology
13. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
    Bhupendra Odhavji Khatri, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Ludwig Kappos, Xavier Montalbán, Jean Pelletier, Tracy E. Stites, Stacy Wu, Fred K. Holdbrook et al. · 2011 · The Lancet Neurology
14. A Quantitative Study of Water Diffusion in Multiple Sclerosis Lesions and Normal-Appearing White Matter Using Echo-Planar Imaging
    Massimo Filippi, Giuseppe Iannucci, Mara Cercignani, Maria Assunta Rocca, A. Pratesi, Gıancarlo Comı · 2000 · Archives of Neurology
15. Defining interferon β response status in multiple sclerosis patients
    Richard A. Rudick, Jar‐Chi Lee, Jack H. Simon, Richard M. Ransohoff, Elizabeth Fisher · 2004 · Annals of Neurology
16. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
    Lauren B. Strober, Jessica J. Englert, F. E. Munschauer, B. Weinstock‐Guttman, Stephen M. Rao, RHB Benedict · 2009 · Multiple Sclerosis Journal
17. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial
    The Multiple Sclerosis Study Group, Wolinsky · 1990 · Annals of Neurology
18. Natural history of secondary-progressive multiple sclerosis
    Helen L. Tremlett, Yinshan Zhao, Virginia A. Devonshire · 2008 · Multiple Sclerosis Journal
19. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging
    Marco Rovaris, Giuseppe Iannucci, Monica Falautano, Francesca Possa, Vittorio Martinelli, Giancarlo Comi, Massimo Filippi · 2002 · Journal of the Neurological Sciences
20. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings
    M.R. Piras · 2003 · Journal of Neurology Neurosurgery & Psychiatry
21. Cognitive and psychosocial features in childhood and juvenile MS
    Maria Pia Amato, Benedetta Goretti, Angelo Ghezzi, Silvia Lori, Valentina Zipoli, Lucia Moiola, Monica Falautano, Maria Fara De Caro, Rosa Gemma Viterbo, Francesco Patti et al. · 2010 · Neurology
22. Psychosocial correlates of fatigue in multiple sclerosis
    Carolyn Emily Schwartz, Linda Coulthard-Morris, Qi Zeng · 1996 · Archives of Physical Medicine and Rehabilitation
23. Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
    Cohen, Jeffrey A, Reingold, Stephen C, Polman, Chris H, Wolinsky, Jerry S · 2012 · The Lancet Neurology
24. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis
    Anat Achiron, Irena Kishner, Mark Dolev, Yael Stern, Mordechai Dulitzky, Eyal Schiff, Reuven Achiron · 2004 · Journal of Neurology
25. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs)
    Martijn D. Steenwijk, Petra J. W. Pouwels, Marita Daams, Jan Willem van Dalen, Matthan W.A. Caan, Edo Richard, Frederik Barkhof, Hugo Vrenken · 2013 · NeuroImage Clinical
26. Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder
    Sean Joseph Pittock, Michael Harry Barnett, Jeffrey L. Bennett, Achim Berthele, Jerome De Seze, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline A. Palace, Friedemann Paul et al. · 2023 · Annals of Neurology
27. The clinical features, MRI findings, and outcome of optic neuritis in children
    Marta Wilejto, Manohar M. Shroff, J. Raymond Buncic, J. Kennedy, C Goia, Brenda Banwell · 2006 · Neurology
28. Effects of whole-body vibration in patients with multiple sclerosis: a pilot study
    Othmar Schuhfried, Christian Mittermaier, T Jovanovic-Mifsud, Karin Pieber, Tatjana Paternostro‐Sluga · 2005 · Clinical Rehabilitation
29. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study
    Anand J. C. Eijlers, Quinten van Geest, Iris Dekker, Martijn D. Steenwijk, Kim A. Meijer, Hanneke E. Hulst, Frederik Barkhof, Bernard M.J. Uitdehaag, Menno Michiel Schoonheim, Jeroen J.G. Geurts · 2018 · Brain
30. Treatment of Autoimmune Disease by Intense Immunosuppressive Conditioning and Autologous Hematopoietic Stem Cell Transplantation
    Richard K. Burt, Ann E Traynor, Richard M. Pope, James L. Schroeder, Bruce A. Cohen, Karyn H. Karlin, Lorri J. Lobeck, Charles L. Goolsby, Philip Rowlings, Floyd A. Davis et al. · 1998 · Blood
31. Neuromyelitis optica in France
    Nicolas Collongues, Romain Marignier, Hélène Zéphir, Caroline Papeix, Frédéric Blanc, C. Ritleng, Maya Tchikviladzé, Olivier Outteryck, Sandra Vukusic, Marie‐Céline Fleury et al. · 2010 · Neurology
32. Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study
    Baert, Ilse, Freeman, Jennifer, Smedal, Tori, Dalgas, Ulrik, Romberg, Anders, Kalron, Alon, Conyers, Helen, Elorriaga, Iratxe, Gebara, Benoit, Gumse, Johanna et al. · 2014 · Neurorehabilitation and Neural Repair
33. Quantitation of lower physical activity in persons with multiple sclerosis
    Alexander V. Ng, Jane A. Kent‐Braun · 1997 · Medicine & Science in Sports & Exercise
34. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis
    Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D’Amico, Graziella Filippini · 2015 · Cochrane Database of Systematic Reviews
35. A nxiety and depression influence the relation between disability status and quality of life in multiple sclerosis
    A. Cecile J.W. Janssens, Pieter A. van Doorn, Josien B. de Boer, Nynke F. Kalkers, Frans G. A. van der Meché, Jan Passchier, Rogier Q. Hintzen · 2003 · Multiple Sclerosis Journal
36. Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
    Bianca Weinstock‐Guttman, Monika L Baier, Youngmin Park, Joan Feichter, Peterkin Lee Kwen, Eileen Gallagher, Jaya T. Venkatraman, Kulwara Meksawan, Suzanne Deinehert, David Pendergast et al. · 2005 · Prostaglandins Leukotrienes and Essential Fatty Acids
37. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: An independent predictor of mental and physical status
    Giovanni Merlino, Lara Fratticci, C. Lenchig, Mariarosaria Valente, Daniela Cargnelutti, M. Picello, Anna Serafini, Pierluigi Dolso, Gian Luigi Gigli · 2008 · Sleep Medicine
38. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
    B. Parmenter, S. Testa, David J. Schretlen, B. Weinstock-Guttman, R. Benedict · 2009 · Journal of the International Neuropsychological Society
39. Depression and quality of life in multiple sclerosis: Depression and QoL in MS
    Fruewald, S., Loeffler-Stastka, H., Eher, R., Saletu, B., Baumhacki, U. · 2001 · Acta Neurologica Scandinavica
40. Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study
    Sean Joseph Pittock, Robyn L. McClelland, William T. Mayr, Neal W. Jorgensen, Brian G. Weinshenker, John H. Noseworthy, Moses Rodriguez · 2004 · Annals of Neurology
41. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
    Chris Juul Hedegaard, Martin Krakauer, Klaus Bendtzen, Henrik Lund, Finn Thorup Sellebjerg, Claus Henrik Nielsen · 2008 · Immunology
42. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
    Kim, Sung-Min, Woodhall, Mark R., Kim, Ji-Sun, Kim, Seong-Joon, Park, Kyung Seok, Vincent, Angela, Lee, Kwang-Woo, Waters, Patrick · 2015 · Neurology Neuroimmunology & Neuroinflammation
43. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
    Watanabe, Mitsuru, Nakamura, Yuri, Michalak, Zuzanna, Isobe, Noriko, Barro, Christian, Leppert, David, Matsushita, Takuya, Hayashi, Fumie, Yamasaki, Ryo, Kuhle, Jens et al. · 2019 · Neurology
44. Clinical relevance using timed walk tests and ‘timed up and go’ testing in persons with Multiple Sclerosis
    Ylva Elisabet Nilsagård, Cecilia Lundholm, Lars‐Gunnar Gunnarsson, Eva Denison · 2007 · Physiotherapy Research International
45. Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis
    Sarah Cader, Alberto Cifelli, Yasir Abu-Omar, Jacqueline A. Palace, Paul McMahan Matthews · 2005 · Brain
46. Tizanidine
    Antona J. Wagstaff, Harriet M. Bryson · 1997 · Drugs
47. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores
    Richard K. Burt, Bruce A. Cohen, Eric J. Russell, Kenneth Spero, Akash Joshi, Yu Oyama, William J. Karpus, Kehuan Luo, Borko D. Jovanovic, Ann E Traynor et al. · 2003 · Blood
48. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
    Mathilde S. A. Deloire · 2005 · Journal of Neurology Neurosurgery & Psychiatry
49. Physical activity in chronic fatigue syndrome: Assessment and its role in fatigue
    Jan H M M Vercoulen, Ellen Bazelmans, C.M.A. Swanink, J.F.M. Fennis, Jochem M. D. Galama, Peter Joseph Jongen, O.R. Hommes, Jos W. M. van der Meer, Gijs Bleijenberg · 1997 · Journal of Psychiatric Research
50. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women
    Jolijn J Kragt, Barbara M. van Amerongen, Joep Killestein, Christine D. Dijkstra, Bernard M.J. Uitdehaag, Chris H. Polman, Paul T.A.M. Lips · 2008 · Multiple Sclerosis Journal
51. Serial Neuropsychological Assessment and Magnetic Resonance Imaging Analysis in Multiple Sclerosis
    Marika J. Hohol, Charles R.G. Guttmann, Endel John Orav, Glenn A. Mackin, Ron Kikinis, Samia Joseph Khoury, Ferenc Andras Jolesz, Howard L. Weiner · 1997 · Archives of Neurology
52. The Relationship Between Diffuse Axonal Damage and Fatigue in Multiple Sclerosis
    Maria Carmela Tartaglia, Sridar Narayanan, Simon J. Francis, Antônio Carlos dos Santos, Nicola De Stefano, Yves Lapierre, Douglas Lorne Arnold · 2004 · Archives of Neurology
53. The treatment of chronic progressive multiple sclerosis with cladribine.
    Ernest Beutler, J.C. Sipe, John S. Romine, James A. Koziol, Robert McMillan, Jack Zyroff · 1996 · Proceedings of the National Academy of Sciences
54. TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
    Klaus‐Peter Wandinger, Jan D. Lünemann, Oliver Wengert, Judith Bellmann–Strobl, Orhan Aktaş, Alexandra Weber, Eva Grundström, Stefan Ehrlich, K.‐D. Wernecke, Hans‐Dieter Volk et al. · 2003 · The Lancet
55. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study
    Christian Veauthier, Helena Radbruch, Gunnar Gaede, Caspar F. Pfueller, Jan R. Dörr, Judith Bellmann–Strobl, K-D Wernecke, Frauke Zipp, Friedemann Paul, J P Sieb · 2011 · Multiple Sclerosis Journal
56. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐ 11 C]‐2‐(4′‐methylaminophenyl)‐ 6‐hydroxybenzothiazole
    Bruno Stankoff, Leorah A. Freeman, Marie‐Stéphane Aigrot, Audrey Chardain, Frédéric Dollé, Anna Williams, Damien Galanaud E, Lucie Armand, Stéphane Lehéricy, Catherine Lubetzki et al. · 2010 · Annals of Neurology
57. MRI T2 lesion burden in multiple sclerosis
    DKB Li, Ulrike Held, John Petkau, Martin Däumer, Frederik Barkhof, Franz Fazekas, Joseph A. Frank, Ludwig Kappos, DH Miller, Jack H. Simon et al. · 2006 · Neurology
58. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients
    Catherine J. Archibald, Patrick J. McGrath, Paul G. Ritvo, John D. Fisk, Virender Bhan, Charles E. Maxner, Thomas J. Murray · 1994 · Pain
59. Depression in multiple sclerosis: Relationship to working memory capacity.
    Peter A. Arnett, Christopher I. Higginson, William D. Voss, William I. Bender, John M. Wurst, Jon Tippin · 1999 · Neuropsychology
60. The Relationship of Sleep Disturbances and Fatigue in Multiple Sclerosis
    Hrayr Pierre Attarian, Kelly M. Brown, Stephen P. Duntley, Jewell Carter, Anne Haney Cross · 2004 · Archives of Neurology
61. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study
    Justin Penner, Omar Abdel‐Mannan, Karlie Grant, Sue Maillard, Filip Kučera, Jane K. Hassell, Michael Eyre, Zoe E. Berger, Yael Hacohen, Karyn L. Moshal et al. · 2021 · The Lancet Child & Adolescent Health
62. Randomised Trial of Oral and Intravenous Methyl-prednisolone in Acute Relapses of Multiple Sclerosis
    D Barnes, RAC Hughes, Richard William Morris, O Wade-Jones, Peter Brown, Thomas C. Britton, David A. Francis, G D Perkin, Peter Rudge, Michael Swash et al. · 1997 · The Lancet
63. Gray matter damage predicts the accumulation of disability 13 years later in MS
    Massimo Filippi, Paolo Preziosa, Massimiliano Copetti, Gianna Carla Riccitelli, Mark A. Horsfield, Vittorio Martinelli, Giancarlo Comi, Maria Assunta Rocca · 2013 · Neurology
64. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction
    M W Nortvedt, Trond Riise, K-M Myhr, A-M Landtblom, Åsne Bakke, Harald Nyland · 2001 · Multiple Sclerosis Journal
65. Modafinil in treatment of fatigue in multiple sclerosis
    Udo Zifko, Monika Rupp, Sigrid C. Schwarz, Harald T. Zipko, Eva Maria Maida · 2002 · Journal of Neurology
66. Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter
    Hugo Vrenken, Jeroen J.G. Geurts, Dirk Lucas Knol, L. Noor van Dijk, Vincenzo Dattola, Bas Jasperse, Ronald A. van Schijndel, Chris H. Polman, Jonas A. Castelijns, Frederik Barkhof et al. · 2006 · Radiology
67. Quantification of MRI lesion load in multiple sclerosis: A comparison of three computer-assisted techniques
    J Grimaud, M. Lai, John W. Thorpe, Patrice Adeleine, Liqun Wang, Gareth J. Barker, David L. Plummer, Paul S. Tofts, W. I. McDonald, DH Miller · 1996 · Magnetic Resonance Imaging
68. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
    Antonietta Citterio, L. La Mantia, Gabriele Ciucci, Livia Candelise, Fabio Brusaferri, Rune Midgard, Graziella Filippini · 2000 · Cochrane Database of Systematic Reviews
69. Validation of the Multiple Sclerosis International Quality of Life questionnaire
    M.C. Simeoni, Pascal Auquier, Óscar Fernández, Peter Flachenecker, Sergio Stecchi, Cris S. Constantinescu, Egemen İdıman, A. Boyko, A. G. Beiske, Timothy L. Vollmer et al. · 2007 · Multiple Sclerosis Journal
70. Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis
    Klaus C Fassbender, Roland Schmidt, Reinald Mößner, Udo Kischka, Josy Kühnen, Andreas Schwartz, Michael G. Hennerici · 1998 · Archives of Neurology
71. Sensory function and quality of life in patients with multiple sclerosis and pain
    K. Svendsen, T. Jensen, H. J. Hansen, F. Bach · 2005 · Pain
72. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: Results of a multicenter prospective study
    Marianne de Sèze, P. Raibaut, P. Gallien, A. Even, P. Denys, V. Bonniaud, X. Gamé, G. Amarenco · 2011 · Neurourology and Urodynamics
73. Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study
    Pietro Maggi, Pascal Sati, Govind Nair, Irene C. M. Cortese, Steven Jacobson, Bryan Smith, Avindra Nath, Joan M. Ohayon, Vincent Van Pesch, Gaetano Perrotta et al. · 2020 · Annals of Neurology
74. Amantadine Treatment of Fatigue Associated With Multiple Sclerosis
    Ronald A. Cohen, Marc Fisher · 1989 · Archives of Neurology
75. Management of Multiple Sclerosis
    Richard A. Rudick, Jeffrey A. Cohen, Bianca Weinstock‐Guttman, Revere Philip Kinkel, Richard M. Ransohoff · 1997 · New England Journal of Medicine
76. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis
    RS Prakash, Emily Snook, Jm Lewis, R. Motl, A. Kramer · 2008 · Multiple Sclerosis
77. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients
    Christopher Christodoulou, Lauren Krupp, Z. Liang, Wei Chieh Huang, Patricia Melville, C. Roque, WILLIAM F. SCHERL, Tom C Naunton Morgan, William S. MacAllister, L. Li et al. · 2003 · Neurology
78. The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot study
    Domien Gijbels, Ilse Lamers, Lore Kerkhofs, Geert Alders, Els Knippenberg, Peter Feys · 2011 · Journal of NeuroEngineering and Rehabilitation
79. Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations
    Mark Steven Freedman, Daniel H. Selchen, Douglas Lorne Arnold, Alexandre Prat, Brenda Banwell, Michael Yeung, David Morgenthau, Yves Lapierre · 2013 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
80. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis
    M. K. Sharief, E J Thompson · 1992 · Journal of Neuroimmunology
81. Information processing characteristics in subtypes of multiple sclerosis
    Leo M. J. de Sonneville, Jan Boringa, I. E. W. Reuling, R.H.C. Lazeron, Herman J. Adèr, Chris H. Polman · 2002 · Neuropsychologia
82. Subcortical atrophy and cognition
    Menno Michiel Schoonheim, Veronica Popescu, Fernanda Cristina Rueda Lopes, Oliver T. Wiebenga, Hugo Vrenken, Linda Douw, Chris H. Polman, Jeroen J.G. Geurts, Frederik Barkhof · 2012 · Neurology
83. Excitatory Amino Acids and Multiple Sclerosis
    Paola Sarchielli, Laura Greco, Ardesio Floridi, A. Floridi, Virgilio Gallai · 2003 · Archives of Neurology
84. Cognitive Disturbances in Patients With Relapsing Remitting Multiple Sclerosis
    W. W. Beatty, Donald E. Goodkin, Neetha R Monson, Peter A. Beatty · 1989 · Archives of Neurology
85. A serial study of new MS lesions and the white matter from which they arise
    Donald Eliot Goodkin, W. Rooney, R. Sloan, P. Bacchetti, L. Gee, M. Vermathen, E. Waubant, M. Abundo, S. Majumdar, S. Nelson et al. · 1998 · Neurology
86. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Antonietta Valli, Alessandro Sette, Ludwig Kappos, Carla Oseroff, John Sidney, G Miescher, Martina Hochberger, E D Albert, Luciano Adorini · 1993 · Journal of Clinical Investigation
87. Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse
    Yann Mikaeloff, Guillaume Caridade, B. Husson, Samy Suissa, Marc Tardieu · 2006 · European Journal of Paediatric Neurology
88. Long–term exercise improves functional impairment but not quality of life in multiple sclerosis
    Anders Romberg, Anita Virtanen, Juhnai Ruutiainen · 2005 · Journal of Neurology
89. Validation of Italian multiple sclerosis quality of life 54 questionnaire
    Alessandra Solari, Graziella Filippini, Laura Mendozzi, Angelo Ghezzi, Stefania Cifani, Elena Barbieri, S. Baldini, Andrea Salmaggi, L. La Mantia, Mariangela Farinotti et al. · 1999 · Journal of Neurology Neurosurgery & Psychiatry
90. Effect of vitamin D 3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
    Margitta T. Kampman, Linn Hofsøy Steffensen, Svein Ivar Mellgren, Lone Jørgensen · 2012 · Multiple Sclerosis Journal
91. Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination
    Setty M. Magaña · 2011 · Archives of Neurology
92. Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
    Richard K. Burt, Roumen D. Balabanov, Xiaoqiang Han, Basil Sharrack, Amy Morgan, Kathleen Quigley, Kim Yaung, Irene Helenowski, Borko Jovanovic, Dzemila Spahovic et al. · 2015 · JAMA
93. The neuroinflammatory component of gray matter pathology in multiple sclerosis
    Elena Herranz, C. Giannì, C. Louapre, C. Treabă, S. T. Govindarajan, R. Ouellette, M. Loggia, Jacob A. Sloane, N. Madigan, D. Izquierdo-García et al. · 2016 · Annals of Neurology
94. Antidepressant pharmacotherapy of depression associated with multiple sclerosis
    Randolph B. Schiffer, NANCY MARGARET WINEMAN · 1990 · American Journal of Psychiatry
95. Evidence of interferon β-1a dose response in relapsing-remitting MS
    The Once Weekly Interferon for MS Study Group (OWIMS) · 1999 · Neurology
96. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy
    R. Benedict, D. Ramasamy, F. Munschauer, B. Weinstock-Guttman, R. Zivadinov · 2008 · Journal of Neurology Neurosurgery & Psychiatry
97. A comparison of health utility measures for the evaluation of multiple sclerosis treatments
    John D. Fisk · 2004 · Journal of Neurology Neurosurgery & Psychiatry
98. Walking and talking: an investigation of cognitive—motor dual tasking in multiple sclerosis
    Frances M. Hamilton, Lynn Rochester, Lorna Paul, Danny Rafferty, CP O'Leary, JJ Evans · 2009 · Multiple Sclerosis Journal
99. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study.
    Anthony Feinstein, Luke D. Kartsounis, David H. Miller, Bryan D. Youl, María A. Ron · 1992 · Journal of Neurology Neurosurgery & Psychiatry
100. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets
     Arnaud Charil, Alex P. Zijdenbos, Jonathan Taylor, Cyrus G. Boelman, Keith J. Worsley, Alan Charles Evans, Alain Dagher · 2003 · NeuroImage